Brief: Jilin Province Huinan Changlong Bio-pharmacy Posts H1 Revenue Of RMB 435 million
BRIEF-Jilin Province Huinan Changlong Bio-pharmacy Posts H1 Revenue Of RMB 435 million Aug 14 (Reuters) - Jilin Province Huinan Changlong Bio-pharmacy
- H1 net income attributable RMB 122.8 million.
- H1 revenue RMB 435 million
Recent news on Jilin Province Huinan Changlong Bio-pharmacy
See all newsJilin Changlong Bio-pharmacy interim profit rises on lower costs
Brief: Jilin Province Huinan Changlong Bio-pharmacy Posts H1 Revenue Of RMB 435 million
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Profit For Year Attributable Rmb198.9 Million
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes To ICBC Structured Deposit Product
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes To ICBC Wealth Management Product For RMB50 MLN